• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor

€0.0

round
investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

$300k

Early VC
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2020202120222023
Revenues0000000000000000
EBITDA0000000000000000
Profit0000000000000000
EV0000000000000000
EV / revenue00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x
R&D budget0000000000000000

Source: Dealroom estimates

Notes (0)
More about Ambient Clinical Analytics
Made with AI
Edit

Ambient Clinical Analytics provides clinical decision support tools for hospitals, focusing on high-acuity environments like the Intensive Care Unit (ICU), Operating Room, and Emergency Department. The company was established in 2014 as a spin-off from the Mayo Clinic, founded by a team of five Mayo Clinic clinicians and CEO Al Berning, a technology entrepreneur with experience leading a company to an IPO. Berning's background includes serving as an Entrepreneur in Residence at Mayo Clinic, where he worked on commercializing a set of AI-based analytics tools for patient care.

The company's core business revolves around licensing its AWARE™ (Ambient Warning and Response Evaluation) platform, which integrates with a hospital's existing Electronic Medical Record (EMR) system. Revenue is generated through software license fees, Software-as-a-Service (SaaS) models, and system integration services. Ambient Clinical Analytics leverages technologies licensed from the Mayo Clinic, incorporating over 1,200 clinically validated rules and algorithms to process patient data in real-time. This enables the platform to deliver actionable insights and alerts to clinicians at the point of care.

The product suite aims to reduce information overload for medical staff by presenting complex patient data through an intuitive, icon-based visualization interface. Key offerings include tools for managing critical care patients and "sniffers" or smart alerts for life-threatening conditions like sepsis and ventilator-induced lung injury. For instance, the Sepsis DART™ (Detection and Response Tool) is designed to help care teams monitor and manage treatment protocols for sepsis. By providing a comprehensive, at-a-glance view of a patient's condition, the software allows clinicians to make faster, more informed decisions, which helps to improve patient outcomes and reduce healthcare costs. The company has secured significant regulatory milestones, including FDA Class II Clearance, CE Marking for sales in the European Economic Area, and ISO 13485:2016 certification for its medical device quality management system.

Keywords: clinical decision support, healthcare analytics, patient monitoring, critical care, ICU technology, EMR integration, sepsis detection, real-time analytics, medical software, Mayo Clinic spin-off, AWARE platform, clinical surveillance, hospital workflow, point-of-care technology, health data visualization, patient safety, Al Berning, operating room tools, emergency department software, medical algorithms, Sepsis DART, FDA cleared medical device

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo